---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-058495"
form_type: "8-K"
ticker: "SXTP"
cik: "0001946563"
company_name: "60 DEGREES PHARMACEUTICALS, INC."
filed_at: "2026-05-18T20:33:00+00:00"
generated_at: "2026-05-18T20:44:22.699110+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# 60 Degrees Pharmaceuticals appoints Eric Francois to Board of Directors

## Summary
- Eric Francois appointed to board effective May 13, 2026; compensation consistent with standard non-employee director arrangements.
- Francois brings over 20 years of healthcare and life sciences leadership; currently independent director at CERo Therapeutics (CERO).
- Previously CFO of SCYNEXIS (SCYX), raised over $300M through FDA approval and launch; earlier MD in healthcare investment banking at Raymond James and Credit Suisse.
- No family relationships or material transactions with company; appointment not pursuant to any arrangement with others.

## SEC filing metadata
- accession: 0001213900-26-058495
- form_type: 8-K
- ticker: SXTP
- cik: 0001946563
- company_name: 60 DEGREES PHARMACEUTICALS, INC.
- filed_at: 2026-05-18T20:33:00+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1946563/000121390026058495/0001213900-26-058495-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1946563/000121390026058495/ea0291366-8k_60degrees.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-058495
- JSON: https://secwatch.observer/filing/0001213900-26-058495.json
- Plain text: https://secwatch.observer/filing/0001213900-26-058495.txt

## Key facts
- Executive change
  Eric Francois was appointed as Member of the Board at 60 DEGREES PHARMACEUTICALS, INC..
  - Action: appointed
  - Role: Member of the Board
  source text: On May 13, 2026, the Board of Directors (the “Board”) of 60 Degrees Pharmaceuticals, Inc. (the “Company”) appointed Eric Francois to serve as a member of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1946563/000121390026058495/0001213900-26-058495-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.